Assertio Holdings, Inc. (ASRT)
Jun 16, 2026 - ASRT was delisted (reason: merged with Zydus Lifesciences)
23.50
+0.02 (0.09%)
Inactive · Last trade price on Jun 15, 2026
Assertio Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 102.16 | 118.71 | 124.96 | 152.07 | 156.23 | 111.01 | |
Revenue Growth | -14.16% | -5.00% | -17.83% | -2.67% | 40.73% | 4.46% |
Cost of Revenue | 30.31 | 35.38 | 39.23 | 27.02 | 18.75 | 15.83 |
Gross Profit | 71.85 | 83.33 | 85.73 | 125.05 | 137.49 | 95.18 |
Selling, General & Admin | 66.46 | 69 | 75.05 | 78.64 | 46.79 | 52.64 |
Depreciation & Amortization Expenses | 26.44 | 29.86 | 25.64 | 27.53 | 32.61 | 28.11 |
Research & Development | 1.71 | 1.69 | 3.82 | 2.84 | - | - |
Other Operating Expenses | 4.02 | 4.31 | 5.69 | 259.58 | 18.69 | 5 |
Total Operating Expenses | 98.62 | 104.87 | 110.21 | 368.59 | 98.08 | 85.76 |
Operating Income | -26.78 | -21.54 | -24.48 | -243.54 | 39.41 | 9.42 |
Interest Income | 2.41 | 2.67 | 3.22 | 2.4 | - | - |
Interest Expense | -3.09 | -3.08 | -3.04 | -3.38 | -7.96 | -10.22 |
Other Non-Operating Income (Expense) | -8.01 | -7.99 | 2.77 | -9.54 | -0.28 | 0.24 |
Total Non-Operating Income (Expense) | -8.68 | -8.4 | 2.95 | -10.52 | -8.24 | -9.98 |
Pretax Income | -35.46 | -29.94 | -21.53 | -254.05 | 31.17 | -0.55 |
Provision for Income Taxes | 0.24 | 0.44 | 0.05 | 77.89 | -78.46 | 0.73 |
Net Income | -30.78 | -30.38 | -21.58 | -331.94 | 109.63 | -1.28 |
Net Income to Common | -30.78 | -30.38 | -21.58 | -331.94 | 109.63 | -1.28 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 6 | 6 | 6 | 5 | 3 | 3 |
Shares Outstanding (Diluted) | 7 | 6 | 6 | 5 | 4 | 3 |
Shares Change | 3.54% | 0.82% | 34.12% | 29.93% | 26.64% | 64.71% |
EPS (Basic) | -5.54 | -4.74 | -3.40 | -70.05 | 34.95 | -0.45 |
EPS (Diluted) | -5.69 | -4.74 | -3.40 | -70.05 | 30.45 | -0.45 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -7.08 | -28.18 | 26.41 | 48.98 | 78.32 | 5.47 |
Free Cash Flow Growth | - | - | -46.08% | -37.47% | 1331.88% | - |
Free Cash Flow Per Share | -1.07 | -4.40 | 4.16 | 10.34 | 21.49 | 1.90 |
Gross Margin | 70.33% | 70.19% | 68.61% | 82.23% | 88.00% | 85.74% |
Operating Margin | -26.21% | -18.14% | -19.59% | -160.15% | 25.22% | 8.49% |
Profit Margin | -30.13% | -25.59% | -17.27% | -218.28% | 70.17% | -1.15% |
FCF Margin | -6.93% | -23.74% | 21.13% | 32.21% | 50.13% | 4.93% |
EBITDA | -0.2 | 8.47 | 1.35 | -215.31 | 72.8 | 38.5 |
EBITDA Margin | -0.20% | 7.13% | 1.08% | -141.59% | 46.60% | 34.68% |
EBIT | -26.78 | -21.54 | -24.48 | -243.54 | 39.41 | 9.42 |
EBIT Margin | -26.21% | -18.14% | -19.59% | -160.15% | 25.22% | 8.49% |
Effective Tax Rate | -0.66% | -1.45% | -0.24% | -30.66% | -251.75% | -131.65% |